Botanix Pharmaceuticals Limited (BOT.AX)
AUD 0.36
(-4.05%)
AUD 0.36
(-4.05%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 | 3.73 Million AUD | 97.99% |
| 2023 | 1.88 Million AUD | -67.97% |
| 2022 | 5.88 Million AUD | 411.76% |
| 2021 | 1.15 Million AUD | -31.31% |
| 2020 | 1.67 Million AUD | -63.48% |
| 2019 | 4.58 Million AUD | 221.6% |
| 2018 | 1.42 Million AUD | 202.93% |
| 2017 | 470.6 Thousand AUD | -8.77% |
| 2016 | 515.82 Thousand AUD | 463.23% |
| 2015 | 91.58 Thousand AUD | -70.44% |
| 2014 | 309.84 Thousand AUD | -87.65% |
| 2013 | 2.5 Million AUD | 6.71% |
| 2012 | 2.35 Million AUD | 3.42% |
| 2011 | 2.27 Million AUD | 22.57% |
| 2010 | 1.85 Million AUD | 62.88% |
| 2009 | 1.13 Million AUD | 5.28% |
| 2008 | 1.08 Million AUD | 79.27% |
| 2007 | 603.47 Thousand AUD | 112.57% |
| 2006 | 283.89 Thousand AUD | 27.17% |
| 2005 | 223.24 Thousand AUD | 22.92% |
| 2004 | 181.61 Thousand AUD | -37.22% |
| 2003 | 289.29 Thousand AUD | -36.82% |
| 2002 | 457.87 Thousand AUD | 170.4% |
| 2001 | 169.33 Thousand AUD | 43.51% |
| 2000 | 118 Thousand AUD | -98.54% |
| 1999 | 8.06 Million AUD | -44.8% |
| 1998 | 14.61 Million AUD | -19.8% |
| 1997 | 18.21 Million AUD | -4.79% |
| 1996 | 19.13 Million AUD | -35.62% |
| 1995 | 29.71 Million AUD | 31.96% |
| 1994 | 22.52 Million AUD | 14.41% |
| 1993 | 19.68 Million AUD | 35.61% |
| 1992 | 14.51 Million AUD | -0.16% |
| 1991 | 14.53 Million AUD | 6.72% |
| 1990 | 13.62 Million AUD | 15.26% |
| 1989 | 11.81 Million AUD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 FY | 3.73 Million AUD | 97.99% |
| 2024 Q2 | 2.29 Million AUD | 0.0% |
| 2024 Q4 | 3.73 Million AUD | 0.0% |
| 2023 Q2 | 4.01 Million AUD | 0.0% |
| 2023 Q4 | 1.88 Million AUD | 0.0% |
| 2023 FY | 1.88 Million AUD | -67.97% |
| 2022 FY | 5.88 Million AUD | 411.76% |
| 2022 Q4 | 5.88 Million AUD | 0.0% |
| 2022 Q2 | 2.89 Million AUD | 0.0% |
| 2021 Q2 | 1.88 Million AUD | 0.0% |
| 2021 FY | 1.15 Million AUD | -31.31% |
| 2021 Q4 | 1.15 Million AUD | 0.0% |
| 2020 Q2 | 2.38 Million AUD | 0.0% |
| 2020 Q4 | 1.67 Million AUD | 0.0% |
| 2020 FY | 1.67 Million AUD | -63.48% |
| 2019 FY | 4.58 Million AUD | 221.6% |
| 2019 Q2 | 1.64 Million AUD | 0.0% |
| 2019 Q4 | 4.58 Million AUD | 0.0% |
| 2018 Q4 | 1.42 Million AUD | 0.0% |
| 2018 FY | 1.42 Million AUD | 202.93% |
| 2018 Q2 | 846.49 Thousand AUD | 0.0% |
| 2017 Q4 | 470.6 Thousand AUD | 0.0% |
| 2017 FY | 470.6 Thousand AUD | -8.77% |
| 2017 Q2 | 398.59 Thousand AUD | 0.0% |
| 2016 Q2 | 176.63 Thousand AUD | 0.0% |
| 2016 Q4 | 515.82 Thousand AUD | 0.0% |
| 2016 FY | 515.82 Thousand AUD | 463.23% |
| 2015 FY | 91.58 Thousand AUD | -70.44% |
| 2015 Q4 | 91.58 Thousand AUD | 0.0% |
| 2014 Q4 | 309.84 Thousand AUD | 0.0% |
| 2014 FY | 309.84 Thousand AUD | -87.65% |
| 2013 Q4 | 2.5 Million AUD | 0.0% |
| 2013 FY | 2.5 Million AUD | 6.71% |
| 2012 FY | 2.35 Million AUD | 3.42% |
| 2012 Q4 | 2.35 Million AUD | 0.0% |
| 2011 FY | 2.27 Million AUD | 22.57% |
| 2011 Q4 | 2.27 Million AUD | 0.0% |
| 2010 Q4 | 1.85 Million AUD | 0.0% |
| 2010 FY | 1.85 Million AUD | 62.88% |
| 2009 FY | 1.13 Million AUD | 5.28% |
| 2009 Q4 | 1.13 Million AUD | 0.0% |
| 2008 FY | 1.08 Million AUD | 79.27% |
| 2008 Q4 | 1.08 Million AUD | 0.0% |
| 2007 FY | 603.47 Thousand AUD | 112.57% |
| 2007 Q4 | 603.47 Thousand AUD | 0.0% |
| 2006 Q4 | 283.89 Thousand AUD | 0.0% |
| 2006 FY | 283.89 Thousand AUD | 27.17% |
| 2005 FY | 223.24 Thousand AUD | 22.92% |
| 2005 Q4 | 223.24 Thousand AUD | 0.0% |
| 2004 FY | 181.61 Thousand AUD | -37.22% |
| 2004 Q4 | 181.61 Thousand AUD | 0.0% |
| 2003 Q4 | 289.29 Thousand AUD | 0.0% |
| 2003 FY | 289.29 Thousand AUD | -36.82% |
| 2002 FY | 457.87 Thousand AUD | 170.4% |
| 2002 Q4 | 457.87 Thousand AUD | 0.0% |
| 2001 FY | 169.33 Thousand AUD | 43.51% |
| 2001 Q4 | 169.33 Thousand AUD | 0.0% |
| 2000 FY | 118 Thousand AUD | -98.54% |
| 2000 Q4 | 118 Thousand AUD | 0.0% |
| 1999 FY | 8.06 Million AUD | -44.8% |
| 1999 Q4 | 8.06 Million AUD | 0.0% |
| 1998 FY | 14.61 Million AUD | -19.8% |
| 1997 Q4 | 18.21 Million AUD | 0.0% |
| 1997 FY | 18.21 Million AUD | -4.79% |
| 1996 FY | 19.13 Million AUD | -35.62% |
| 1995 FY | 29.71 Million AUD | 31.96% |
| 1994 FY | 22.52 Million AUD | 14.41% |
| 1993 FY | 19.68 Million AUD | 35.61% |
| 1992 FY | 14.51 Million AUD | -0.16% |
| 1991 FY | 14.53 Million AUD | 6.72% |
| 1990 FY | 13.62 Million AUD | 15.26% |
| 1989 FY | 11.81 Million AUD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| AdAlta Limited | 3.54 Million AUD | -5.35% |
| Acrux Limited | 5.68 Million AUD | 34.375% |
| Actinogen Medical Limited | 1.61 Million AUD | -131.036% |
| AnteoTech Limited | 4.07 Million AUD | 8.421% |
| Argenica Therapeutics Limited | 2.42 Million AUD | -53.791% |
| Arovella Therapeutics Limited | 2.05 Million AUD | -81.465% |
| Anatara Lifesciences Ltd | 306.84 Thousand AUD | -1116.258% |
| Alterity Therapeutics Limited | 5.42 Million AUD | 31.215% |
| Amplia Therapeutics Limited | 3.42 Million AUD | -8.909% |
| Avecho Biotechnology Limited | 941.54 Thousand AUD | -296.38% |
| Bio-Gene Technology Limited | 368.44 Thousand AUD | -912.924% |
| Biome Australia Limited | 5.37 Million AUD | 30.544% |
| Biotron Limited | 737.5 Thousand AUD | -406.039% |
| BTC Health Limited | 203.94 Thousand AUD | -1729.916% |
| Chimeric Therapeutics Limited | 12.8 Million AUD | 70.85% |
| CSL Limited | 27.88 Billion AUD | 99.987% |
| Clarity Pharmaceuticals Ltd | 8.33 Million AUD | 55.207% |
| Clinuvel Pharmaceuticals Limited | 28.11 Million AUD | 86.724% |
| Cynata Therapeutics Limited | 1.17 Million AUD | -218.694% |
| Dimerix Limited | 13.89 Million AUD | 73.137% |
| EZZ Life Science Holdings Limited | 4.22 Million AUD | 11.753% |
| Hexima Limited | 248.67 Thousand AUD | -1400.815% |
| Island Pharmaceuticals Limited | 1.04 Million AUD | -256.923% |
| Immuron Limited | 2.84 Million AUD | -31.387% |
| Immutep Limited | 10.97 Million AUD | 66.009% |
| Imugene Limited | 33.14 Million AUD | 88.74% |
| Invex Therapeutics Ltd | 431.63 Thousand AUD | -764.647% |
| Memphasys Limited | 5.59 Million AUD | 33.265% |
| Nanollose Limited | 465.64 Thousand AUD | -701.489% |
| Neuren Pharmaceuticals Limited | 42.76 Million AUD | 91.273% |
| Noxopharm Limited | 1.28 Million AUD | -189.619% |
| NeuroScientific Biopharmaceuticals Limited | 85.68 Thousand AUD | -4255.68% |
| Nyrada Inc. | 855.63 Thousand AUD | -336.177% |
| Orthocell Limited | 22.08 Million AUD | 83.099% |
| PharmAust Limited | 896.6 Thousand AUD | -316.244% |
| Patrys Limited | 691.36 Thousand AUD | -439.813% |
| Paradigm Biopharmaceuticals Limited | 3.58 Million AUD | -4.122% |
| Proteomics International Laboratories Limited | 1.62 Million AUD | -129.536% |
| Prescient Therapeutics Limited | 2.32 Million AUD | -60.481% |
| PYC Therapeutics Limited | 10.18 Million AUD | 63.354% |
| Race Oncology Limited | 1.91 Million AUD | -94.742% |
| Radiopharm Theranostics Limited | 44.68 Million AUD | 91.648% |
| Recce Pharmaceuticals Ltd | 15.89 Million AUD | 76.518% |
| Starpharma Holdings Limited | 8.69 Million AUD | 57.093% |
| Telix Pharmaceuticals Limited | 249.39 Million AUD | 98.504% |
| Tissue Repair Ltd | 1.35 Million AUD | -176.265% |
| Zelira Therapeutics Limited | 9.35 Million AUD | 60.113% |